In a meeting held on December 20, 2024, the Fund Raising Committee of the company had approved the issue of 1.19 crore equity ...

Mumbai: The National Green Tribunal (NGT) has dismissed allegations of water pollution against the Ambernath plant of Bharat ...

Advent International has been present in India since 2007 and has committed over $6 billion in that time, spread across 19 ...

Mankind Pharma, India’s fourth-largest pharmaceutical company by domestic sales, has officially launched its Rs 3,000 crore ...

The pharma company has acquired 100% stake in BSV for ₹13,768 crore, to be funded through a combination of internal accruals ...

Mankind Pharma has launched a Rs 3,000 crore QIP to fund its acquisition of Bharat Serums and Vaccines. The company has seen ...

Mankind Pharma is a top pharma company. It is the 4th largest pharma company in the country. Mankind Pharma has launched QIP ...

The QIP opened on December 16, 2024, with Mankind Pharma keeping the option to offer a discount of up to 5% on the floor ...

The indicative issue price for the QIP is expected to be approximately ₹2,520 per share, which could lead to an equity ...

The proposed capital raise is part of Mankind Pharma's plan to fund the Rs 13,630-crore acquisition of private equity firm ...

Scheduled for 21st of January at The Constitution Club, New Delhi, this monumental gathering will center on the theme: “Education’s Role in Building a Viksit Bharat by 2047.” As India marches towards ...

The department offers flu, COVID-19, Tdap and RSV vaccines to adults and children for little to no cost this season. Flu and COVID-19 cases traditionally peak in the winter. Since the week of Nov ...